Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology: Page 25
AIUM: TRUS or MRI for prostate diagnosis?
By
Kate Madden Yee
ORLANDO, FL - Although multiparametric MRI may be widely considered now as the go-to exam for detecting prostate cancer and guiding biopsies, transrectal ultrasound (TRUS) can still be a viable option, according to a presentation at the American Institute of Ultrasound in Medicine (AIUM) meeting.
April 9, 2019
Prostate cancer incidence, mortality decline worldwide
By
Abraham Kim
The incidence and mortality rates of prostate cancer have stabilized or declined in most countries throughout the world in recent years, according to research presented at the American Association for Cancer Research (AACR) 2019 meeting in Atlanta.
April 2, 2019
Standardized accreditation is key for prostate MRI
By
Edna Astbury-Ward, PhD
Quality in imaging is never guaranteed -- that is why working toward European-wide accreditation for prostate MRI is the way forward, expert speakers explained at this morning's ECR Master Class. Benchmarking quality in acquisition and reporting must be set within clear clinical pathways, and it is a vital part of the accreditation process.
March 2, 2019
Ga-68 PSMA-11 PET/MRI improves prostate cancer detection
By
Wayne Forrest
VIENNA - PET/MRI with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) could become a valuable tool in image-guided biopsy and for detecting significant prostate cancer, researchers reported on Wednesday at ECR 2019.
February 28, 2019
MRA is cost-effective for kidney disease-related aneurysms
By
Wayne Forrest
Optimizing costs with beneficial patient outcomes is a constant goal in healthcare. In that regard, the use of MR angiography (MRA) to screen and follow up patients who may have intracranial aneurysms linked to kidney disease can work well from both cost and clinical perspectives, according to a study published online February 19 in
Radiology
.
February 20, 2019
Shorter radiotherapy works for prostate cancer treatment
By
Kate Madden Yee
A shorter radiotherapy protocol for treating prostate cancer is comparable to a conventional radiotherapy schedule when it comes to disease-free survival and quality of life after treatment, according to a new study published online February 15 in
JAMA Oncology
.
February 18, 2019
AI singles out high-risk prostate cancer on mpMRI
By
Erik L. Ridley
Working with radiomics data on multiparametric MRI (mpMRI) scans, an artificial intelligence (AI) algorithm was able to distinguish between low-risk and high-risk prostate cancer more accurately than the current risk assessment approach used by radiologists, according to research published online February 7 in
Scientific Reports
.
February 7, 2019
Did Image Gently reduce CT use for kidney stones?
By
Abraham Kim
The CT utilization rate for children with kidney stones has gradually decreased in recent years, but researchers from Michigan are questioning whether the Image Gently safe-imaging initiative is the cause of the trend. Their findings were published online January 28 in the
Journal of Urology
.
February 3, 2019
Prostatic artery embolization gains clinical momentum
By
Jamal Al Deen Alkoteesh
Prostate artery embolization has emerged as a highly promising interventional radiology procedure for lower urinary tract symptoms secondary to benign prostatic hypertrophy, Dr. Jamal Al Deen Alkoteesh told Arab Health delegates on the final day of the Total Radiology conference in Dubai, United Arab Emirates.
January 31, 2019
IsoRay's cesium-131 brachytherapy aids prostate surgery
By
AuntMinnie.com staff writers
Researchers from the Medical University of South Carolina have used medical isotope developer IsoRay's Blu Build isotope cesium-131 brachytherapy delivery device to facilitate prostate cancer surgery.
January 29, 2019
ANMI inks deal for SPECT radiopharmaceutical
By
AuntMinnie.com staff writers
Advanced Nuclear Medicine Ingredients (ANMI) has signed an agreement to license a clinical-stage SPECT radiopharmaceutical for prostate cancer imaging from the Mexican Instituto Nacional de Investigaciones Nucleares.
January 24, 2019
MRI-based grading scheme eases prostate cancer evaluation
By
Wayne Forrest
Researchers from the U.S. National Cancer Institute and National Institutes of Health have developed a standardized grading system using multiparametric MRI results and certain clinical markers to simplify the assessment of prostate cancer spread, according to a study published online January 22 in
Radiology
.
January 23, 2019
Previous Page
Page 25 of 93
Next Page